Market research
TDAC Translational Development Acquisition Corp. Ordinary Shares
NASDAQ USD Financial Services
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 209M
- P/E ratio
- 41.71
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Financial Services
- Industry
- Shell Companies
- ISIN
- KYG9008W1050
- Market cap
- 209M
- P/E ratio
- 41.71
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
About
About Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the TDAC discussion.
5 years, 4 months ago
Trident Acquisitions Corp is currently in a long term uptrend where the price is trading 3.2% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Trident Acquisitions Corp's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 201.7% to $-191K since the same quarter in the previous year.
Finally, its free cash flow grew by 24.5% to $-246K since the same quarter in the previous year.
Based on the above factors, Trident Acquisitions Corp gets an overall score of 3/5.